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been doused somewhat by recent eviden~ that genetically 
engineered human insulin is associated with an impaired 
recognition of hypoglycaemia. 
Although this book gives broad coverage, an important 
therapeutic area not mentioned is that of the renin-angiotensin 
system. Some of the peptide analogues of angiotensin ! 1are potent 
receptor antagonists and would have had great potential as 
pharmaceuticals bat for their poor pharmaeokinetic 
characteristics and unwanted pharmacological effects. Many of 
the shortcomings of these peptides have been overcome by the 
more traditional approach of designing and synthesising small 
drug molecules. A further omission relates to the use of transgenie 
cattle, sheep and goats to produce human proteins in their milk. 
This process, termed 'pharming', is at the experimental stage and 
offers considerable potential for the large scale production ofthese 
pharmaceuticals. 
Despite these criticisms, the book represents a useful 
introduction to polypeptide and protein drugs. It is up to date 
(many 1990 references), attractively presented and well illustrated. 
Although 1 suspect some of the chapters will contain too much 
technical detail for the more general reader, many pharmaceutical 
scientists will find it a valuable addition to their libraries. 
M.S. Lennard 
Biological Oxidation of Nitrogen in Organic Molecules - -  Progress in Pharmacology and Clinical Pharmacology, Volume 8, 
No. 3; Edited by P. Hlaviea and L.A. Damani; Gustav Fischer Verlag; Stuttgart/New York, 1991; x + 351 pages; DMI79.00 
Study of a nitrogenous chemical, namely 2-acetylaminofluorene, 
by the Weisbargers some two decades ago led to the appreciation 
of the role of the metabolism in the manifestation of toxicity/ 
carcinogenicity, and interest in these compounds has not subsided. 
On the contrary, the discovery of various carcinogenic 
heterocyclic amines in food, being formed during the process of 
cooking, sparked new world-wide interest in the metabolism and 
toxicology of these compounds. 
The book comprises the Proceedings of an International 
Symposium held in Munich in September, 1989 and constitutes the 
3rd part of the 8th volume in the series "Progress in Pharmacology 
and Clinical Pharmacology'. There are more than thirty 
contributions, primarily by scientists from academia, divided into 
three sections. The first deals with the occurrence and analytical 
techniques used in the determination of N-oxidised metabolites. 
ranging from TLC to NMR spectroscopy. The enzyme systems 
catalysing N.oxidation are the subject of the second section. It is 
quite refreshing to see so much emphasis being given to the flavin 
monooxygenase system, frequently outshone by its more 
illustrious neighbour, the cytochromes P-450 which, surprisingly 
are largely ignored in this book despite being the most important 
oxidases mediating the metabolic activation of most carcinogenic 
nitrogeneous chemicals, a regrettable omission. The final section 
is concerned with the toxicological consequences of phase ! and 
I1 metabolism of these compounds in rive and in vitro, and the 
molecular mechanisms leading to cell toxicity. 
Despite being a multi-author eflbrt, the editors ensured that the 
style is uniform throughout, each chapter is preceded by a 
summary, and an invaluable attribute is the inclusion of the 
chemical structures of the substrates in question, enabling the 
reader to obtain maximum benefit. Overall, an informative and 
up.to-date book, excellently illustrated and immaculately 
presented that will grace any bookshelf, large or small. 
C. ioannides 
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Marcel Dekker; New York, 1990; xxiv ~- 712 pages; $180.00 
This rather weighty tome, running to 712 pages, has undergone 
a radical metamorphosis since the first edition was published a 
little over ten years ago. This reflects the many advances we have 
made in understanding the underlying cell biology of the 
malignant process. The rapid evolution of immanodiagnostic 
methods in the detection and characterization f cancer has also 
contributed profoundly to this change. Back in 1979, monoclonal 
antibodies were still little more than interesting research tools 
which had yet to make the strategic leap to become the backbone 
of many modern diagnostic assays. With 39 chapters contributed 
by as many individuals/groups it must have been a Herculean task 
for the editors to ensure dead-lines were met. For this they have 
my undying admiration as 1 know only too well how difficult it 
can be to ensure contributors meet deadlines. The invention of the 
fax machine has exacerbated this problem, since many an editor 
has received illegible eleventh our drafts from authors, who now 
feeling they have done their duty under perceived Considerable 
editorial duress, disappear into research laboratories or on 
eatending vacations beyond the reach of normal communication 
channels. 
In general terms the book is well balanced with the initial five 
chapters covering experimental designs, focusing on areas uch as 
predictive value of tests and their statistical analysis. This section 
provides a thorough theoretical grounding to the diagnostic tests 
that so many of us use on a routine basis. Chapters ix to fourteen 
deal with the basis of diagnostic methodology with the aim of 
giving the reader an insight into the underlying 'chemistry' of 
immunodiagnostie ests. This topic is largely dealt with on a 
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